Involvement of endogenous opioid systems in nociceptin-induced spinal antinociception in rats.

Long-Chuan Yu,Jiang-Teng Lu,Yan-Hua Huang,Thomas Meuser,Christian Pietruck,Anja Gabriel,Stefan Grond,Pamela Pierce Palmer
DOI: https://doi.org/10.1016/S0006-8993(02)02743-9
IF: 3.61
2002-01-01
Brain Research
Abstract:The present study investigates the involvement of opioid receptors in the antinociceptive effects of nociceptin in the spinal cord of the rat. Intrathecal administrations of 5 and 10 nmol of nociceptin significantly increase the withdraw response latencies to noxious thermal and mechanical stimulations. This nociceptin-induced antinociceptive effect is significantly attenuated by intrathecal injection of (Nphe1)nociceptin(1–13)-NH2, a selective antagonist of the nociceptin receptor (opioid receptor-like receptor ORL1), indicating an ORL1 receptor-mediated mechanism. This antinociceptive effect is also significantly attenuated by intrathecal injections of naloxone (a nonselective opioid receptor antagonist), naltrindole (a selective δ-opioid receptor antagonist), and β-funaltrexamine (a selective μ-opioid receptor antagonist) in a dose-dependent manner, but not by the selective κ-opioid receptor antagonist norbinaltorphimine. Since it is unlikely that nociceptin acts by direct binding to opioid receptors, these results suggest a possible interaction between the nociceptin/ORL1 and opioid systems in the dorsal horn of the rat spinal cord.
What problem does this paper attempt to address?